The Cancer Letter

Inside information on cancer research and drug development

Guest Editorial

Leading a matrix cancer center: Extensive responsibility, modest influence, little authority

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

As is true in so many fields, medicine and biomedical research have experienced a huge transition over recent decades from self-sufficiency to productive interdependence. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
George J. Weiner, MD
Director emeritus, Holden Comprehensive Cancer Center; CE Block Chair of Cancer Research, Professor of internal medicine, Professor of pharmaceutical sciences and experimental therapeutics, The University of Iowa
Table of Contents

YOU MAY BE INTERESTED IN

Health Equity

Solving problems doctors can’t fix: How Georgetown’s medical-legal partnership saves lives by including lawyers on cancer care teams
Why every cancer center needs a Cancer LAW Project

By the end of 2022, Toni Monteiro had no fight left in her. She had been battling a rare blood cancer for three years. Her husband had just died. She was at risk of being evicted from her Washington, DC, apartment. Also, her heart was failing. “You’re really under stress,” Monteiro recalls her physician saying. ...

By Matthew Bin Han Ong
Byline
George J. Weiner, MD
Director emeritus, Holden Comprehensive Cancer Center; CE Block Chair of Cancer Research, Professor of internal medicine, Professor of pharmaceutical sciences and experimental therapeutics, The University of Iowa
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account